Valuation: Rapid Dose Therapeutics Corp.

Market Cap 12.28M 8.73M 7.58M 7.07M 6.49M 830M 12.41M 83.33M 32.58M 415M 32.79M 32.07M 1.38B P/E 2025
-3.92x
P/E 2026 -5.88x
Enterprise Value 17.59M 12.51M 10.86M 10.12M 9.3M 1.19B 17.78M 119M 46.66M 595M 46.96M 45.93M 1.97B EV / Sales 2025
11.8x
EV / Sales 2026 9.23x
Free-Float
84.93%
Yield 2025 *
-
Yield 2026 -
07-30 Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 31, 2026 CI
07-29 Rapid Dose Therapeutics Corp And Bodhi Health Inc Expand Distribution And Sales Of CurcuWIN QuickStrip Curcumin Across Canada CI
07-06 Rapid Dose Therapeutics Corp. and Global Nicotine Leader Extend Strategic Collaboration for Quickstrip Dissolvable Oral Nicotine Strip Technology CI
06-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 28, 2026 CI
06-28 Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt CI
04-13 Rapid Dose Therapeutics Corp Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets CI
04-06 Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt MT
03-05 Rapid Dose Therapeutics And Aavishkar Oral Strips Secure Patent For Quickstrip Nicotine Bilayer Oral Film CI
02-23 Rapid Dose Therapeutics Corp. Advances Cannabinoid Research and Clinical Evaluation of QuickStrip Platform CI
02-10 Rapid Dose Therapeutics Corp. Launches QuickStrip? Medical Cannabis for Patients in Brazil CI
01-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2025 CI
25-10-30 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2025 CI
25-08-05 Rapid Dose Therapeutics Corp. Submits QuickStrip®? Nicotine Product for Health Canada CI
1 day-23.25%
1 week-12.60%
Current month-23.25%
1 month-22.70%
3 months-30.07%
6 months-21.05%
Current year-33.33%
1 week 0.06
Extreme 0.06
0.06
1 month 0.06
Extreme 0.06
0.09
Current year 0.01
Extreme 0.0132
0.12
1 year 0.01
Extreme 0.006
0.15
3 years 0
Extreme 0.0021
0.39
5 years 0
Extreme 0.0004
1.11
10 years 0
Extreme 0
1.11
Manager TitleAgeSince
Chief Executive Officer - 2017-05-02
Director of Finance/CFO - 2020-02-27
Corporate Officer/Principal - 2019-12-05
Director TitleAgeSince
Chairman - -
Director/Board Member - 2024-08-05
Director/Board Member - 2020-08-12
Change 5-day change 1-year change 3-year change Capi.($)
-23.25%-12.60% - - 8.73M
+1.89%+11.56%-34.72%-55.96% 104M
-0.26%+1.48%+4.71%-59.89% 95.06M
+0.48%+4.33%+93.58%+16.25% 80.25M
Average -4.95%+5.55%+21.19%-33.20% 93.27M
Weighted average by Cap. +0.40%+5.83%+15.47%-36.59%

Financials

2025 2026
Net sales 2.09M 1.48M 1.29M 1.2M 1.1M 141M 2.11M 14.15M 5.53M 70.49M 5.57M 5.45M 234M 2.77M 1.97M 1.71M 1.6M 1.47M 188M 2.8M 18.82M 7.36M 93.75M 7.4M 7.24M 311M
Net income -5.4M -3.84M -3.34M -3.11M -2.86M -365M -5.46M -36.67M -14.34M -183M -14.43M -14.11M -605M -3.39M -2.41M -2.09M -1.95M -1.79M -229M -3.43M -23M -8.99M -115M -9.05M -8.85M -380M
Net Debt 2.59M 1.84M 1.6M 1.49M 1.37M 175M 2.62M 17.57M 6.87M 87.53M 6.91M 6.76M 290M 5.31M 3.77M 3.28M 3.06M 2.81M 359M 5.37M 36.03M 14.09M 180M 14.18M 13.87M 595M
Logo Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Employees
-
Date Price Change Volume
26-08-04 US$0.0600 -23.25% 10,000
26-07-29 US$0.0782 +13.87% 6,666
26-07-28 US$0.0687 -5.18% 500